RECRUITING

Attentional Bias Modification Training for E-cigarette Users

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.

Official Title

Attentional Bias Modification Training for E-cigarette Users

Quick Facts

Study Start:2021-06-09
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05112562

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 29 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 and 29 years
  2. * Those who use ENDS exclusively, not combining with other tobacco, for 3 consecutive months
  3. * Those who own a smartphone.
  1. * Current medication or psychosocial treatment for ENDS dependence
  2. * Serious alcohol-use problems (≥ 26 points on the Alcohol Use Disorders Identification Test)
  3. * Ophthalmic conditions impeding eye-tracking
  4. * Current psychiatric/psychosocial treatment for other mental health disorders in the DSM-5 (e.g., schizophrenia)
  5. * Pregnancy.

Contacts and Locations

Study Contact

Seok Hyun Gwon, PhD, RN
CONTACT
414-229-6462
gwon@uwm.edu
Han Joo Lee, PhD
CONTACT
leehj@uwm.edu

Principal Investigator

Seok Hyun Gwon, PhD, RN
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Milwaukee

Study Locations (Sites)

University of Wisconsin-Milwaukee
Milwaukee, Wisconsin, 53211
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Milwaukee

  • Seok Hyun Gwon, PhD, RN, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Milwaukee

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-06-09
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2021-06-09
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • E-cigarette Use
  • Tobacco Use Cessation